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UNDERSTANDING THE MECHANISM AND EXTENT OF VLSE RECOMBINATION IN 
BORRELIA BURGDORFERI USING NEXT-GENERATION SEQUENCING 
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B. burgdorferi, the causative agent of Lyme disease, have an elaborate antigenic 
variation system that involves varying the sequence of vlsE. Previous studies have 
shown that vlsE antigenic variation occurs continuously inside mammalian hosts. 
Variation has not been shown previously to occur in in vitro or in ticks. We 
hypothesized that the induction of vlsE recombination requires contact with dense 
arrays of host tissue cells and/or ECM components. To test this hypothesis, two 
methods, quantitative PCR and high-throughput sequencing were used determine the 
extent and nature of vlsE recombination within mouse tissues and in vitro model 
systems. Using these approaches, we were able to detect vlsE variants in axenic 
cultures of B. burgdorferi as well as co-cultures with mouse skin and heart tissues; 
these results were compared with those from mice infected for 7 days.  Analysis of 
PacBio single molecule real-time (SMRT) sequencing indicated the presence of 0.84% 
to 1.18% variants in pure in vitro cultures and 0.79% to 1.22% in tissue explants, as 
compared 36% to 57% for organisms from mouse bladder tissue 7 days post 
inoculation.  Statistical evaluation of the variants showed that the rate of 
recombination in tissue explants was not significantly different from the rate of 
recombination in in vitro cultures. Thus, tissue explant co-cultures do not seem to 
promote a higher recombination rate than in in vitro axenic culture. Moreover, high-
throughput PacBio sequencing was found to be an effective means of analyzing single 
molecule sequencing variation in the robust vlsE antigenic variation system. 
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Borrelia Spirochetes 
 
Borrelia is a genus that belongs to the spirochete phylum Spirochetes and the order 
Spirochaetales [1].  Like Leptospira and Treponema, other members of the Spirochete 
phylum, Borrelia are motile bacteria with a distinctive helical shape and an outer 
membrane. Of all the members of the spirochete phylum, Borrelia species are the only ones 
that require an arthropod vector for vertebrate host transmission. There are currently 36 
known Borrelia species, and 15 Lyme disease species; the latter group is also known as 
Borrelia burgdorferi sensu lato (“in a general sense”). It was proposed recently that the 
Borrelia genus be reorganized into two genera: Borreliella for the Lyme disease group and 
Borrelia for the relapsing fever organisms [2]. 
Lyme disease Borrelia 
 
Of the B. burgdorferi sensu lato species, the three that cause the most human disease 
are B. garinii, B. afzelii, and B. burgdorferi sensu stricto (“in a strict sense”) [1].  B. 
burgdorferi sensu stricto is the predominant causative agent of Lyme disease in the United 
States, although another species, provisionally called ‘Borrelia mayonii’, was recently 
described [3]. Infections caused by B. garinii and B. afzelii are frequently found in Europe 
and Asia. 
Approximately 35,000 cases were reported to the Centers for Disease Control and 
Prevention (CDC) in the year 2013. However, a recent analysis by the CDC indicated that 
the actual incidence in the U.S. is over 300,000 cases per year [4]. Symptoms of Lyme 
disease include skin lesions, arthritis, carditis, and neurologic deficits. The name of Lyme 
disease originates from the town of Lyme, Connecticut, where clusters of pediatric and 
adult arthritis cases were occurring [5]. These cases were studied and were thought to 
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represent a new clinical entity, initially named Lyme arthritis. Later studies showed that 
the syndrome was associated with the bite of Ixodes ticks, commonly resulting in a bulls-
eye shaped rash called erythema migrans. The causative organism, later called B. 
burgdorferi, was first cultured from ticks in 1981 [6]. 
Clinical manifestations of Lyme disease 
Lyme disease as an illness can be divided into three stages, with each stage 
presenting different clinical manifestations [7]. The early manifestations of Lyme disease 
(stage one) include erythema migrans, low-grade fever, malaise and fatigue. Although the 
lesions are localized, the organism has already begun to disseminate and can be isolated 
from blood in many cases. The antibody response starts to develop, but is not consistently 
detected in all patients. At the disseminated stage (stage 2) many patients experience 
intermittent episodes of migratory musculoskeletal pain and attacks of asymmetric 
arthritis in large joints, especially the knee. Eventually, the disease becomes persistent 
(stage 3) and the episodes of arthritis become longer, lasting for months to years. Despite 
the availability of effective antibiotic treatment for Lyme disease, some patients experience 
post-treatment Lyme disease syndrome (PTLDS) where they continue to have symptoms.  
PTLDS is a highly controversial topic in the scientific community; there is a no universally 
accepted diagnosis and treatment for PTLDS. Moreover, the underlying mechanism of 
PTLDS is unknown; some scientists believe that the post-infectious autoimmunity is the 
cause of PTLDS, while others attribute the disease to persistent B.burgdorferi infection [8].   
Diagnosis and treatment of Lyme disease 
The diagnosis of Lyme disease is based primarily on clinical manifestations and 
history, with support from serologic tests. In the U.S., a two-step laboratory testing process 
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for Lyme disease is utilized [9]. First, an Enzyme-Linked Immunosorbent Assay (ELISA) is 
performed to test the antibody response to a B. burgdorferi lysate or a mixture of 
recombinant antigens. Then, those test samples with positive ELISA results are examined 
by immunoblotting to detect IgM and IgG antibodies against individual Borrelia proteins. A 
positive IgM immunoblot is only useful during the first 4-weeks of infection. IgG antibodies 
are more reliable but can take 4-6 weeks to develop. 
Treatment of Lyme disease consists of an initial 14 to 21 day course of oral 
doxycycline or amoxicillin [10]. Some patients require an additional 30-day antibiotic 
treatment. If patients have symptoms such as joint swelling or neuroborreliosis, they are 
placed on a 4-week course of IV ceftriaxone therapy. These treatments are effective in 
eradicating symptoms in most cases, but roughly 10% of patients have lingering symptoms 
called post-treatment Lyme disease syndrome. New oral antibiotics approved by the FDA, 
including daptomycin, carbomycin, have shown effectiveness against spirochetes in 
culture, but there are no data yet to support if they work in patients with Lyme disease. 
Borrelia burgdorferi genome 
B. burgdorferi (Bb) has a highly unusual genome, consisting of a linear chromosome 
and 21 circular and linear plasmids that range from 5 to 56 kilobases in size. Linear 
plasmid names begin with lp, and circular plasmids begin with cp; both end with a number 
that indicates the plasmid size in kilobases (e.g., lp54, cp9). B. burgdorferi strain B31 has a 
linear chromosome of approximately 910 kb and 21 plasmids totaling 610 kb [11]. The 
overall G+C content of the genome is 28.6%. Studies have shown that certain B. burgdorferi 
plasmids are associated with infectivity. For instance, organisms lacking lp28-1 exhibit 
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intermediate-infectivity (recovery of organisms up to two weeks after inoculation), while 
the loss of lp25 results in low-infectivity phenotype [12, 13]. 
The chromosomes of all Borrelia organisms have a high degree of synteny [14]. 
Although the overall gene content of the plasmids of B. garinii, B. afzelii and B. burgdorferi 
is generally well conserved, extensive intraplasmidic recombinations are evident in 
different species and strains. 
Vector tick Ixodes scapularis 
Lyme disease is transmitted to humans by the bite of infected ticks of the genus 
Ixodes. I. scapularis is the vector in the Eastern and North Central U.S., whereas I. pacificus is 
the agent in the western U.S.  I. ricinus and I. persulcatus are the vectors in Europe and Asia 
respectively [15]. 
Lyme disease transmission cycle 
 
The enzootic cycle of B. burgdorferi begins with eggs laid by adult female ticks in the 
spring (Figure 1.1). The larvae hatch in the summer and can acquire Borrelia when they 
take their first blood meal from infected small mammals or birds. After feeding, the larvae 
molt and undergo metamorphosis into nymphal ticks.  The ticks take a second blood meal 
during the following spring.  Nymphal ticks are able to transmit Borrelia to larger mammals 
including humans and are responsible for the majority of Lyme disease cases. Humans are 
an accidental host of Lyme disease and represent a ‘dead end’ in the transmission process. 
Next, the nymphal ticks molt into the adult stage.  Adult females feed on large mammals, 
such as deer, and lay eggs in the spring, thus starting the two-year cycle all over again. 
Adult female ticks can lay up to 3000 eggs and die just a few days afterwards [4]. 
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Differential expression of outer surface lipoproteins in B. burgdorferi during the 
transmission cycle 
During its transmission cycle, B. burgdorferi goes through many environmental 
changes as it is transferred between the tick and mammalian hosts.  Differential gene 
expression of lipoproteins plays a major role in the ability of the organism to adapt to 
different hosts [16]. As an example, outer surface protein A (OspA) is encoded on lp54 and 
is predominantly expressed in the midgut of an infected unfed tick. When an unfed 
nymphal tick begins to feed on a mammalian host, the environment in the midgut changes 
from a pH of 7.4 to pH 6.8 and the temperature changes from ~22 ºC to near 37 ºC. During 
feeding, OspA expression is down-regulated while OspC expression is up-regulated, and 
spirochetes migrate from the midgut to the salivary glands. OspC plays an important role in 
the transmission and initial dissemination of Borrelia from the tick in the mammalian host, 
and its expression peaks after 48 hours of feeding [17]. 
Decorin-binding proteins DbpA and DbpB, also encoded lp54, are expressed during 
mammalian infection but not in ticks [18].  These proteins mediate adherence to decorin, a 
proteoglycan that ‘decorates’ the surface of collagen fibrils in some tissues. Tissues with 
high decorin expression, such as skin, joints, and endothelium are thought to function as 
protective niches for Borrelia. Another adhesive lipoprotein is BBK32. This protein binds to 
glycosaminoglycans (GAGs) and fibronectin (Fn), a complex glycoprotein present in plasma 
and extracellular matrix (ECM). Studies have shown that the interaction of BBK32 with 
GAGs and Fn play an important role in the dissemination, colonization and persistence of 
Borrelia in the mammalian host [19]. 
Overview of antigenic variation systems 
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Antigenic variation is a mechanism by which an infectious agent can alter the 
sequence of its antigenic surface proteins. The alteration of surface protein sequence 
allows the infectious agent to escape the host immune response and thus promote long-
term infection [20]. Antigenic variation systems hinder the development of vaccines for 
many pathogens.   
One example of a vector-borne pathogen that undergoes antigenic variation is 
Trypanosoma brucei, a protozoan transmitted to mammals by tsetse flies. T. brucei 
continuously switch their expression of variant-surface glycoproteins (VSGs) surface 
protein [21]. Of the ~2000 VSG genes and pseudogenes, only one is transcriptionally active 
while others remain silent. The silent VSG genes, which are located in clusters of large 
arrays within the subtelomeric region of the 11 Mb chromosomes, can be copied into one of 
15 telomeric VSG expression site (ES) through gene conversion. In early stages of infection, 
an entire silent VSG gene replaces the ES.  In the later stages of infection, segmental gene 
conversion emerges as an additional mechanism of VSG switching. Segmental gene 
conversion of multiple silent VSG genes can result in endless possibilities of new chimeric 
VSGs. 
Neisseria gonorrhoeae, a human pathogen that is the causative agent of the sexually 
transmitted disease gonorrhea, also has an antigenic variation system that involves 
variation of their Type IV pilin [21]. Segments of pilS silent cassettes are unidirectionally 
transferred into the pilE expression locus through a gene conversion process. The copies of 
pilS sequences are predominantly variable regions while the expressed pilE sequence 
contains both variable and invariable regions. The recombination between pilS and pilE 
involves replacement of pilE segments by pilS sequences, leaving the pilS sequence 
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unchanged and creating a hybrid pilE sequence. The length and region of DNA replacement 
in a recombination event can also vary.  Recent data from the Seifert group showed that 
pilin antigenic variation involves a guanine quartet (G4) structure [22]. Their later studies 
showed that G-rich sequence can only form a G4 structure when a pilE G4-associated sRNA 
was transcribed [23]. 
The causative agents of relapsing fever, such as Borrelia hermsii, also have antigenic 
variation systems that involve varying variable major proteins (Vmps) [24].  B. hermsii 
plasmids have a single Vmp expression site and ~40 silent gene segments that encode 
variable large proteins (Vlps) and variable small proteins (Vsps). Gene conversion occurs 
between a silent vsp or vlp gene segment and the expression site. Studies have shown that 
the vlp or vsp sequence at the expression site is usually replaced completely by a silent vlp 
or vsp gene segment [25]. This process involves recombination at upstream and 
downstream homology sequences. Similar to B. hermsii, the antigenic variation system in 
Borrelia burgdorferi involves gene conversion between the vmp-like sequence expression 
site (vlsE) and the silent vls cassettes, as described below. 
The vls antigenic variation system 
 
The vls antigenic variation system was first described in B. burgdorferi in 1997 [26] 
and is present in all Lyme disease Borrelia strains thus far characterized [27]. The gene 
encoding the 35 kDa outer surface protein VlsE undergoes extensive recombination during 
mammalian infection. In ticks and in in vitro culture, VlsE is expressed, but recombination 
had not been detected in these environments prior to the research presented in this thesis 
[28]. 
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The antigenic variation system of B. burgdorferi consists of varying the sequence of 
VlsE, a surface localized lipoprotein [29].  The VlsE protein is encoded by vlsE, a gene 
located on a 28 kb linear plasmid (lp28-1) in B. burgdorferi B31. The vlsE expression site is 
downstream of 15 silent cassettes that are not expressed (Figure 1.2 A).  There is 90% to 
96.1% sequence homology between the 15 silent cassettes and the central cassette region 
of vlsE. Each cassette has 6 variable regions (VRs) and 6 relatively invariant regions (IRs). 
Most of the sequence differences between vlsE and the vls silent cassettes occur within the 
6 variable regions (Figure 1.2 B). The recombination events include not only nucleotide 
changes but also codon-length (multiple of threes) indels. There is 76.9% to 91.4% 
predicted amino acid identity, consistent with the fact that most of the nucleotide 
differences are non-synonymous. Figure 1.2 C shows an example of gene conversion events, 
where portions of the central vlsE cassette region are replaced by segments of silent 
cassettes 9, 7 and 10 sequentially.  The first B. burgdorferi B31 vlsE allele described is called 
vlsE1.  All the vlsE recombination experiments reported herein use clones with the vlsE1 
sequence; this sequence is therefore referred to as the parental sequence. 
Previous studies in our laboratory [29], where 1,399 clones isolated from B. 
burgdorferi B31-infected mouse tissues were analyzed, showed that there is an increased 
frequency and complexity of vlsE sequence changes as the days post infection increase. 
Immunocompetent C3H/HeN and severe combined immunodeficiency (SCID) mice were 
infected with a B31 clone, and tissues from sacrificed mice were taken at days 4, 7, 10, 14 
and 28 days post infection.  Recombination events were observed in ~50% of organisms 
recovered from infected C3H/HeN mice 4 days post inoculation, indicating that the 
recombination process begins early in the course of infection. Borrelia clones with the 
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‘parental’ vlsE sequence are cleared more rapidly in immunocompetent mice than in SCID 
mice, indicative of immune elimination of clones with invariant VlsE sequences. By day 28 
post-infection, no clones with the vlsE parental sequence were found in the 
immunocompetent mice. In SCID mice, however, vlsE variants were isolated in increasing 
numbers throughout the course of infection, but sequence changes accumulated more 
gradually and clones with the parental sequence were still detected on day 28 post-
infection. Thus, the presence of an adaptive immune response is not required to induce vlsE 
recombination, but non-variant bacteria appear to be eliminated by the immune response. 
Recombination events were distributed throughout the vlsE cassette, showing no 
preference for a particular region within the cassette. 
The length of recombination events ranged from single nucleotide change to almost 
the entire vlsE cassette [29]. Due to high sequence homology among the silent cassettes, a 
single silent cassette donor could not be identified unambiguously in some instances. Many 
variant sequences resulted from multiple recombination events and thus resulted in 
complex sequences with an untraceable lineage. Also, 15% of all the variant clones 
analyzed had template-independent changes (usually single nucleotide substitutions), 
meaning that these changes could not be explained as a gene conversion event between 
vlsE and the 15 silent cassettes. 
Gene conversion in Chicken immunoglobulin genes   
As discussed in the previous sections, many pathogens including B. burgdorferi use 
gene conversion as the mechanism to vary their antigens. Outside of pathogenic 
microorganisms, gene conversion is used as the mechanism to expand and diversify the B-
cell repertoire in Chickens [30]. Diversification of B-cells is essential in allowing the animal 
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immune system to recognize and target a variety of invading bacteria and viruses. The 
expansion of antibodies is the result of B-cells recombining their immunoglobulin genes: 
variable (V), diversity (D) and joining (J). After V(D)J recombination, a unique VJ segment 
is generated. In chicken B-cells; the VJ fragment undergoes gene conversion events, where 
the upstream pseudo V segments act as the template for the unidirectional, segmental 
recombination.  
Characteristics of VlsE protein structure 
 
VlsE is a surface-exposed lipoprotein that has a molecular weight of 35 kDa [26]. 
The crystal structure of VlsE [31] shows that the 6 variable regions form random loop 
structures that comprise most of VlsE membrane-distal surface (Figure 1.3).  It has been 
postulated that the surface exposure of variable regions plays a role in hindering 
interactions of host antibodies with the bacterial surface; this property may help Borrelia 
evade the host immune response. The invariable regions have a structure made up 
primarily of alpha helices with some beta-strands. Conserved N- and C-terminal regions 
flank the central VlsE cassette and also have alpha helical structures. 
Mechanism of vlsE recombination 
Gene conversion, a mechanism that results in a unidirectional exchange between a 
conserved DNA sequence and the ‘targeted’ DNA that undergoes sequence alteration, best 
describes vlsE recombination, although non-templated point mutations have also been 
shown to occur. Previous studies performed by our laboratory show that silent cassettes do 
not change during recombination, further supporting gene conversion as the primary 
mechanism of vlsE recombination [28].  Comprehensive studies, in which mutants of genes 
known to be involved in DNA recombination and repair were analyzed, showed that genes 
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ruvA and ruvB are important in vlsE recombination [32, 33]. RuvA and RuvB form a 
complex that acts as the Holliday junction helicase during homologous recombination. ruvA 
and ruvB mutants had a significantly lower rate of vlsE recombination in C3H/HeN mice. No 
clones with variant vlsE sequences were recovered from ruvA or ruvB mutants in 
immunodeficient (C3H/scid) mice 28 days post infection, further indicating that the 
recombination rate was greatly reduced in these mutants. mutS mutants also displayed a 
minor effect on vlsE recombination [33]. Mutation of the other genes examined, including 
recA, did not have a significant effect on vlsE recombination rates [32-34]. Other than the 
involvement of ruvA and ruvB and the potential involvement of mutS, the proteins and 
recombinases involved in the vlsE recombination remain unknown. 
vls sequences have an unusually high GC content of ~50% while the rest of the 
genome has a GC content of ~28% [35].  There is also a high GC skew in vls sequences (with 
a higher G content on the coding strand), which likely contributes to the recombination 
process. It has been postulated that polymeric G stretches present in the vlsE cassette 
region may promote the formation of secondary structures such as G-quadruplex within 
vlsE, which could help mediate recombination at the expression locus [35].  Attempts to 
mutate the vlsE locus (and thus identify cis-acting elements) have been unsuccessful to 
date. 
Unlike most antigenic variation systems, vlsE recombination has not been detected 
in vitro [36] .This finding indicates that the activation of vlsE recombination may be 
triggered by conditions specific to the mammalian host.  One of the goals of this project was 
to evaluate whether a tissue explant model system could provide a ‘tissue-like’ 
environment and thus induce a higher number of vlsE variants than in pure culture. If this 
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were the case, the tissue explant system would provide a good in vitro model system to 
study vlsE recombination, making the discovery of the trans-acting and cis-acting factors 
involved in vlsE recombination much easier. 
In this study, next-generation sequencing was used to generate a large number of 
vlsE sequences. The availability of these data allowed us to thoroughly analyze the 
occurrence of vlsE recombination in mammalian cell-free (axenic) cultures, tissue explant 
co-cultures and infected mice. Besides examining the rate of recombination, we wanted to 
analyze individual recombination events to see if any patterns emerged.  Patterns in vlsE 
variant sequences could lead to a better understanding of the nature and mechanism of 
vlsE recombination. 
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Figure 1.1 Life cycle of I. scapularis ticks and its relationship to Lyme disease 
transmission 
Blood-fed females lay eggs in late spring. In the summer, the eggs hatch into larvae, which 
feed on Borrelia-infected small vertebrate hosts. In the spring of the following year, larvae 
emerge as nymphal ticks. Typically, from May through June, infected nymphal ticks feed 
and transmit B. burgdorferi to mammalian hosts. In the fall of year two, nymphs molt into 
adults. The females feed on large mammals, mate and lay eggs. Humans are accidental 
hosts, and are more likely to be infected by nymphs because ticks at this stage are smaller 
and, therefore, harder to detect and remove.  Furthermore, adult ticks do not commonly 
feed on humans. (Figure from http://www.cdc.gov/ncidod/dvbid/lyme/ld_transmission.htm.) 
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Figure 1.2 Characteristics of the vls locus and vlsE recombination [27]    
 A. vlsE is located on lp28-1, next to 15 silent cassettes that are highly homologous to each 
other and to the central cassette region of vlsE.  B. Each of the 16 cassettes has 6 variable 
and 6 highly conserved invariant regions. The majority of variant or non-parental amino 
acid sequences are within the variable regions.  C. This panel shows a hypothetical example 
of a homologous, unidirectional, random segmental recombination where vls9 first donates 
part its sequence to the central region of vlsE. Then vls7 donates its sequence, replacing 
part of the sequence that was donated by vls9. Lastly, vls10 donates its sequence to vlsE. 
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Figure 1.3 VlsE protein structure [29] 
a. The conserved N- and C- terminal regions are colored in gray. The variable regions are 
located at the membrane distal surface and are colored in yellow. The 17-bp direct repeat 
regions are shown in red.  
b. VlsE sequence consists of a lipoprotein leader sequence (white) and conserved N- and C- 
terminal regions (gray). vlsE and the 15 silent cassettes are flanked by 17-bp non-
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conserved direct repeat sequence. Each cassette has 6 designated variable regions (yellow) 
and 6 invariable regions (blue). 
c. This image shows the crystal structure of VlsE. The localization of the variable regions to 
the surface of the protein may act to protect the invariable regions from antibody 
interaction.   
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Culture conditions 
B. burgdorferi was grown in Barbour-Stoenner-Kelly (BSK) II medium that was 
prepared in the laboratory [37]. The cultures were incubated at 37°C with 3% CO2, and cell 
densities were counted under darkfield microscopy. Cultures were grown to late log phase 
or early stationary phase, which has a concentration of 107-108 cells per ml. 
Bacterial strains  
B. burgdorferi B31-5A4, a clone that contains all plasmids and has a ‘parental’ allele 
of vlsE1, is the bacterial strain that was used primarily in these studies. Strain B31 was 
initially derived by Alan Barbour through a series of limiting dilutions of an extract from 
ticks from Shelter Island, New York.  The B31 strain had undergone three in vitro passages 
when received by our laboratory, and is maintained as stocks at -80°C. B31-5A4 was 
derived from B31 by two sequential colony isolations, and its plasmid content was 
determined by polymerase chain reaction (PCR) [12].  This clone has been used previously 
in animal infectivity studies, in vitro cultures and tissue explant experiments. 5A18NP1 is a 
B31 clone with the ‘parental’ vlsE1 allele that lacks two plasmids (lp28-4 and lp56) and has 
been further modified by disruption of BBE02 [38]. BBE02 and BBQ67 on lp56 encode type 
2 restriction-modification enzymes, and their absence increases the transformation rate of 
B. burgdorferi.  5A18NP1 exhibits an increased transformation efficiency and maintains full 
infectivity in the mouse model [38]. 5A18NP1 was used in one of the mammalian cell-free 
(axenic) culture studies. 
Tissue explant model system 
Dr. Diane Edmondson, a fellow lab member, designed the tissue explant model 
system protocol. Small cubes (1-2 mm3) of mouse skin, heart, bladder, liver and spleen 
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tissue were obtained aseptically from C3H/HeN mice. The explants were placed at the air-
liquid interface on a hydrated collagen matrix (Gelfoam; Upjohn) in 6 well cluster dishes 
containing 1 ml BSK II medium per well. Explants were cultured at 37C in air-3% CO2 for 1 
day prior to the addition of 5 x 105 B. burgdorferi (B31-5A4) per ml of medium. Starting on 
Day 1 of co-culture, the medium was removed and then replaced with fresh medium every 
2-3 days.  At different time points, explants were removed for fixation and staining. 
Genomic DNA was isolated from parallel samples. 
Mouse infection studies 
A total of 18 C3H/HeN immunocompetent female mice (6-8 weeks of age) were 
used for the animal studies. A low passage frozen stock sample (2337C) of B31-5A4 was 
selected and grown in BSK II medium to 107 organisms per ml.  A volume of 0.1 ml 
containing 105 organisms was used to inoculate the mice. Groups of 4 mice were sacrificed 
on days 7, 14, 28, and 90-post infection (Figure 2.1).  Five tissues (ear, joint, heart, bladder 
and skin) were obtained from each of the mice sacrificed. The tissue specimens were 
cultured for Borrelia in BSK II liquid medium with an antibiotic mixture (phosphomycin, 
rifampicin, amphotericin B) to inhibit the growth of other bacteria.  These cultures were 
grown to 107 organisms per ml (approximately 7 days).  
DNA preparation 
All DNA extractions were done using the DNeasy Blood & Tissue kit (Qiagen). B. 
burgdorferi were cultured in 6 ml liquid BSK II medium and grown to late log phase (~107 
organisms per ml). B. burgdorferi cultures were centrifuged for 15 min at 4700 x g, and the 
supernatant solution was discarded. Cells were resuspended in one ml of BSK II, vortexed 
and transferred to 1.5 ml microcentrifuge tubes. The cells were centrifuged at 13200 x g for 
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6 minutes at 4°C in an Eppendorf 5415R Centrifuge; the supernatant was discarded. The 
centrifuged pellets were resuspended in 180 μl of buffer ATL and 20 μl of proteinase K, 
which induces lysis of cells in order to release DNA, and were incubated overnight in a 56°C 
water bath. The resulting lysates were then subjected to DNA purification according to the 
manufacturer’s instructions and eluted in 150 μl of Tris acetate-EDTA buffer. The 
concentration of the eluted DNA samples was determined using a NanoDrop 
spectrophotometer, and the samples were stored at -20°C. 
Amplification of vlsE cassette 
The vlsE cassette region was amplified by using vlsE-specific primers. Both the 
forward primer 4120 (5'-TAA GTA GTA CGA CGG GGA AAC CAG-3') and the reverse 
primer 4066 (5'-CTT TGC GAA CTG CAG ACT CAG CA -3') are located outside of the 17-
bp direct repeat region at either end of the vlsE central cassette (Figure 1.3B).  PCR 
reactions were performed using Phusion, a high-fidelity DNA polymerase. Five μl of PCR 
products were analyzed by gel electrophoresis on a 0.80% Agarose gel. Then, the PCR 
products were purified using Qiagen’s PCR Purification kit. 
PCR assay to detect vlsE recombination 
To determine if vlsE recombination occurs within tissue explant co-cultures, a PCR 
assay consisting of two primer pairs was used.  Figure 2.1 shows the two primer pairs used 
for the assay. The ‘parental’ primer pair has a forward primer sequence that is specific to 
the ‘parental’ vlsE sequence in variable region (VR) 5, and will amplify any vlsE sequence 
that has an unchanged VR5 region. The ‘variant’ primer amplifies vlsE sequences that have 
undergone variation in VR5 and match the most common vls silent cassette sequence in 
VR5.  Note that the ‘variant’ primers will not be able to detect the presence of all variants, 
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specifically those with a VR5 region identical to that of the parental sequence. Both primer 
pairs have the same reverse primer, 4066, which is specific to the vlsE 3’ region. 
Quantification of parental and variant vlsE sequences using Quantitative PCR 
A quantitative PCR (qPCR) protocol was developed to quantify the copy number of 
‘variant’ and ‘parental’ vlsE sequence in mammalian cell-free (axenic) cultures, tissue 
explant co-cultures and infected mice DNA samples. All qPCR experiments were performed 
using Bio-Rad SYBR Green PCR Master Mix and a Bio-Rad CFX96 Touch Real-Time PCR 
Detection System. The same primer pairs used in the PCR assay to screen for vlsE 
recombinants (Figure 2.1) were used in the qPCR experiments. To quantify the number of 
non-variant and variant vlsE in a sample, qPCR reactions using both ‘variant’ and ‘parental’ 
primers were performed.   
Pacific Biosciences sequencing 
Pacific Biosciences (PacBio) methodologies and equipment were used to sequence 
vlsE PCR products obtained from mice, tissue explant and in vitro samples. We are grateful 
to Dr. George Weinstock and his team, who graciously performed the SMRTbellTM 
procedure (see below) and PacBio sequencing. PacBio uses single molecule real-time 
(SMRT) sequencing, which utilizes the inherent properties of the DNA polymerase as its 
sequencing engine. Phospho-linked nucleotides are used to visualize polymerase activity, 
with each of the four nucleotides (TAGC) attached to a different colored fluorescent label 
(Figure 2.2). These phospho-linked nucleotides carry their fluorescent label on the 
terminal phosphate rather than on the base, and DNA polymerase cleaves the fluorescent 
label as the nucleotides are being incorporated. Sequencing is performed in SMRT cells, 
each of which contains tens of thousands of zero-mode-wave-guides (ZMWs). Individual 
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DNA fragments are sequenced simultaneously in the ZMWs, an optical waveguide 
technology that guides light energy into a small volume, allowing the detection of 
nucleotides being incorporated by the DNA polymerase one at a time. Once a nucleotide is 
incorporated and the fluorescent label is cleaved off, the cleaved fluorescent molecule 
diffuses out of the ZMW detection volume, making the fluorescent signal undetectable. 
For amplicon sequencing, SMRTbellTM hairpin adaptors are ligated on to both ends 
of each amplicon (Figure 2.3). The hairpin adaptors allow circular consensus sequencing 
(CCS), where the forward and reverse strand of the each amplicon can be sequenced 
multiple times. The shorter the amplicon, the higher number of repeated sequencing.  Post 
sequencing, a consensus read is generated by averaging the base calls of the multiple reads. 
If performing multiplex sequencing, where multiple samples can be sequenced in parallel, a 
barcode sequence is added to the SMRTbell adaptor. For our experiment, a unique barcode 
was ligated to each of the 8 samples, and then the amplicons were pooled and sequenced. 
PacBio has a mean read length of 10-15 kb and an error rate of 14% per single read. The 
error rate can be reduced down to ~1% for consensus reads. 
PacBio sequence data workflow 
Initially, we attempted to align the raw consensus sequences against vlsE and vls 
cassettes using ClustalW. The output was aligned very poorly, most likely due to a 
combination of high homology among the cassettes, sequencing errors and three-
nucleotide indels. After failing to align sequences with other software programs, I decided 
to manually align reads.  Instead of attempting to manually align all reads (~30,000 per 
sample), we focused on aligning variant reads. First, I filtered out sequences with read 
lengths less than 601 bp or greater than 680 bp. This read length range was chosen 
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because most likely anything less than 601 bp would be incomplete reads and reads longer 
than 680 bp represented incorrect consensus assemblies and therefore would have too 
many errors. 
To identify variant sequences in the mammalian cell-free in vitro cultures and tissue 
explant samples, BLAST searches using each PacBio sequence as the query sequence and 
the invariant-variant regions (e.g. IR1-VR1) of vlsE1 and all of the vls silent cassettes as the 
subject sequences were performed to identify PacBio sequences that contained regions 
matching silent cassettes. All sequences that had a higher percent identity match with an 
IR-VR sequence of one of the 15 silent cassettes was noted as a potential variant sequence. 
All of the potential variant sequences were then manually aligned against pre-aligned vlsE1 
and the 15 vls cassette sequences. 
During the manual alignment process, the base positions of the deletion and 
insertion errors were recorded and single base indel errors were manually corrected. For 
ambiguous deletion errors, where different nucleotides are present in the cassettes, an 
IUPAC code was used to represent the possible choices.  Also, the most likely base was 
determined by looking at the nucleotides and neighboring regions of vlsE and the 15 silent 
cassettes around position as the error. 
Automation of alignment and error correction 
We collaborated with David Volk, Ph.D. to automate the alignment and error 
correction process. The Aptaligner software utilizes the FASTQ file, a format that combines 
the data of raw reads with quality information, as the input file. The program creates a 
library that consists of all the codons in the vlsE parental sequence and the silent cassettes. 
The raw reads were aligned simultaneously against vlsE codon sequence and all possible 
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silent cassette codons using Hidden-Markov-Modeling (HMM). HMM optimizes the overall 
read alignment by generating alignment scores for multiple alignment possibilities. Once a 
possible alignment and its score are generated, the aligned sequence can only be replaced 
with another aligned sequence of a higher score. The program also counts the number of 
copies of identical reads and removes the non-unique sequences. Post-alignment, a 
realignment script condenses equivalent alignments to optimize the subsequent error 
correction script. Then error corrections are made by comparing codons at each position of 
the read to the library of cassette codons. The program is designed to record the position 
and the correction made. After the correction step, the aligned sequences are readjusted to 
fix any misaligned regions. The realignment and correction steps of this program are 
currently being optimized. 
Analysis of aligned reads 
Recombination events in aligned variant sequences were visualized using a Visual Basic 
macros program [29] developed by Dr. Loic Coutte, a former lab member.  This program 
allowed us to visualize all potential vls cassette donors. It also distinguishes between a 
maximal and minimal recombination event. Each cassette is represented by a different color.  
Solid color regions indicate regions of the variant sequence that match that cassette (but not 
the original vlsE1 sequence).   The hatched color indicates that the variant sequence matches 
both the vlsE1 and the cassette.   A possible minimum recombination event represents the 
largest area that matches a silent cassette region but not the parental vlsE1 sequence.  In the 
program, this region begins and ends with solid color regions, with hatched regions in all 
intervening spaces.  A potential maximal recombination event also includes flanking regions 
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that match both the silent cassette and vlsE1.   This region is the same as the minimal 
recombination event plus the flanking hatched sequences. 
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 IR5 VR5 
Cassette 151 152 153 154 155 156 157 
Vlse1 GCT GCT GCT ATT GGG GAT AAA 
Vsl2 GCT GCT GCT ATT GGG AAG GGT 
Vls3 GCT GCT GCT ATT GGG AAG GGT 
Vls4 GCT GCT GCT ATT GGG AAG GGT 
Vls5 GCT GCT GCT ATT GGG AAG GGT 
Vls6 GCT GCT GCT ATT GGG GAT AAA 
Vls7 GCT GCT GCT ATT GGG AAG GGT 
Vls8 GCT GCT GCT ATT GGG AAG GGT 
Vls9 GCT GCT GCT ATT GGG AAT AAA 
Vls10 GCT GCT GCT ATT GGG AAG GGT 
Vls11 GCT GCT GCT ATT GGG AAG GGT 
Vls12 GCT GCT GCT ATT GGG AAG GGT 
Vls13 GCT GCT GCT ATT GGG AAG GGT 
Vls14 GCT GCT GCT ATT GGG AAG GGT 
Vls15 GCT GCT GCT ATT GGG GAT AAA 
Vls16 GCT GCT GCT ATT GGA AAG GGT 
The ‘Parental’ primer is indicated in red for vlse1, vls6, vls9 and vls15. The ‘Recombined’ 
primer is shown in green for vls2-vls5, vls7-vls8, and vls10-vls15. Vls16 does not fit either 
primer due to codon 155. 
 
Figure. 2.1  ‘Parental’ and ‘variant’ primer sequence used to detect presence 
of vlsE recombinants in both PCR and qPCR assay.   
The two primer pairs used to detect parental and variant vlsE sequences, were 
specific to portions of the IR5 and VR5 region. This region was chosen because 12 
out of the 15 silent cassettes had the seqeuence “AAGGGT” region in the 
beginning of their VR5 region. The ‘parental’ vlsE has the sequence of “GATAAA“ 
in the beginning of its VR5 region. This difference allows the detection of most of 
the vlsE variants that have undergone a change in the VR5 region. 
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Figure 2.2 PacBio single molecule real-time (SMRT) sequencing [39] 
(A) PacBio sequencing occurs within SMRT cells, each of which contains tens of thousands 
of cylindrical zero-mode-waveguide (ZMW) units. Each ZMW has a single DNA polymerase, 
which is fixed to the bottom, and a single DNA fragment.  
(B) When the DNA polymerase incorporates a nucleotide, a laser light is passed through 
the bottom of the ZMW cell, which allows the camera to detect the fluorescent signal 
located the terminal phosphate of the dNTP. The intensity and the color of the signal are 
recorded in real-time by the PacBio instrument. As the next nucleotide is incorporated, the 
fluorescent label from the previous nucleotide is cleaved off and diffuses out of the cell.   
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Figure 2.3 SMRTbell amplicon sequencing  
In PacBio amplicon sequencing, SMRTbell hairpin adaptors (green) are ligated on to the 
DNA fragment (yellow-purple). The SMRTbell dumbbell adapters allows the DNA 
polymerase to sequence the DNA fragment in a circular motion, which in turn results in 
multiple reads of the forward (yellow) and reverse (purple) strand of the amplicon. These 
multiple forward and reverse subreads and are used to generate a circular consensus 
sequence (black). (Figure from http://www.pacb.com/smrt-science/smrt-
sequencing/single-molecule-resolution/)  
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qPCR results 
 
Standardization of qPCR 
 
The purpose of developing a qPCR assay was to use a sensitive method that would 
accurately quantitate the number of variants in different samples and allow us find the rate 
of vlsE recombination in in vitro, tissue explant and animal infection samples. To 
standardize a qPCR protocol, the efficacy of three different primer lengths was tested. The 
primer length of 21 bp was chosen because it produced standard curves with the highest 
efficiency and R2 value (Figure 3.1). It also had the cleanest single peak melt curves (no 
small shoulder peak that suggests the presence of secondary product).  The qPCR 
instrument’s thermal gradient feature was used find the optimal annealing temperature. 
Serial dilution of 5A4 (parental vlsE clone) PCR product was used to generate a 
standard curve for quantifying non-recombinant vlsE. The PCR product of a variant clone, 
1396D, was used to construct standard curve for quantifying recombinant vlsE. 1:10 serial 
dilutions between 0.5 ng/μl and 5 x 10-10 ng/μl were done for 5A4 and 1396d PCR 
products. qPCR results yielded highly reproducible standard curves with high squared 
correlation values (P21 R2=0.993, V21 R2=0.979) (Figure 3.1). It is important to note that 
we were able to detect real variants in mammalian cell-free in vitro culture samples using 
PacBio sequencing (Table 4). Therefore the PCR products from sample 2337C used to 
construct the standard curve to quantitate copies of parental vlsE will contain a small 
proportion of variant sequences. This might lead to a less precise calculation of the copies 
of parental vlsE in samples. 
CT values represent the cycle number at which the amplification fluorescent signal is 
above the background fluorescence, i.e. the number of cycles it took to detect a real signal 
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from a sample. The template DNA concentration for all samples was standardized to 5 ng. 
The CT values represent the average of 3 technical replicates. Sample 2337C with P21 
(parental primer) resulted in a CT value of 23.04 and a higher CT value of 27.77 with primer 
V21 (variant primer) (Table 1). As expected, the reverse was true for the variant clone 
sample 1396D, which had a CT value of 31.95 with primer P21 and a lower CT value of 18.91 
with primer V21. TE47, tissue explant co-culture sample, had CT value of 24.10 with primer 
P21 and CT value of 28.28 with primer V21.   
qPCR reactions with template DNA from 7 (D7M1B), 14 (D14M1B) and 21 
(D21M1B) days post infection mouse bladder tissue were also performed. The results 
showed that as the days post infection increased, the CT value increased with P21, and the 
decreased CT values with primer V21. These trends indicate that the proportion of 
spirochetes with parental vlsE sequence decrease in mouse infection sample between 7 and 
21 day post infection (Table 1).  
Absolute quantification 
For absolute quantification, the P21 standard curve was used to quantitate the 
copies of parental vlsE and the V21 standard curve was used to quantitate the copies of 
variant vlsE in a sample.  First, the standard curve linear equation and CT values were used 
to find the quantity in nanograms (ng) and then converted to copy number. The calculated 
numbers of parental vlsE sequences and variant sequences detected using the V5 region 
primers are provided in Table 2. As expected, 2337C had the highest number of parental 
vlsE sequences and 1396D had the highest number of variant vlsE sequences detected. 
Among the mouse infection samples, the copies of variant vlsE increased while the copies of 
parental vlsE decreased over the days post infection. 
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Figure 3.1 Standard curves for absolute quantification using parental (P21) and 
variant (V21) primers. The standard curve in panel (A) was generated with vlsE PCR 
products from sample 2337C and P21 primer will be used to quantitate the copy number of 
“parental” vlsE in a sample. While the standard curve shown in panel (B) was generated 
using vlsE PCR product from sample 1396D and primer V21 will be used to calculate the 
copies of variant vlsE in samples. 
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Table 1. CT values with ‘parental’ primer P21 and variant primer V21.  
 
Sample name CT 
Primer P21 
CT 
Primer V21 
2337C 22.72 + 0.089 28.41 + 0.216 
1396D 33.6 + 0.134 21.89 + 0.008 
TE47 24.10 + 0.81 28.28 + 0.147 
D7M1B 23.44 + 0.028 26.91 + 0.269 
D14M1B 25.38 + 0.076 24.47 + 0.057 
D28M1B 24.68 + 0.128 23.45 + 0.061 
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Table 2. QPCR as a measure of vlsE recombination.  Calculated copy numbers of parental 
and variant vlsE Variable Region 5 (VR5) sequences were determined for in vitro cultures with 
predominant parental (2337C) and variant (1396D) vlsE sequences, a tissue explant culture 
(TE47), and in mouse bladder tissue 7, 14, and 28 days post inoculation with B. burgdorferi B31, 
clone 2337C (D7M1B, D14M1B, and D28M1B, respectively). 
 
 
Sample name 
 
Copies with parental 
vlsE VR5 sequences 
 
Copies with variant 
vlsE VR5 sequences 
 
Proportion with 
variant VR5 sequences 
(%) 
 
Parental clone (2337C) 3.49x104 1.07x103 2.97 
Variant clone (1396D) 1.89x101 9.77x104 99.98 
Tissue explant (TE47) 1.35x104 1.17x103 7.97 
D7M1B 2.13x104 3.02x103 12.42 
D14M1B 2.52x104 1.64x104 39.42 
D28M1B 9.03x103 3.31x104 78.57 
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Pacbio Results: 
 High-throughput sequencing was the second method used to quantitate the rate of 
vlsE recombination in samples. NGS sequencing generates large amount of data, which 
would allow us to accurately quantitate the number of variants, specifically those that 
occur at very low rate (mammalian cell-free samples). Moreover, it allowed us to study 
individual recombination events within variant sequences. PacBio sequencing was selected 
as the sequencing platform because it has a long read length (10 kb  - 15 kb), and low 
consensus read error rate (~1%). 454 and Illumina have a comparable error rate but have 
shorter amplicon read lengths (~ 300-600 bp) and therefore would not be able to sequence 
the entire vlsE cassette. Moreover, 454 and Illumina synthesize DNA from clonally 
amplified templates, which may result in sequencing bias. We filtered out reads less than 
601 bp to eliminate reads that were shorter than the expected length of the vlsE cassette 
plus the upstream and downstream regions (Table 3). Reads greater than 680 bp were also 
filtered out to remove low quality reads that most likely resulted from misalignment of 
SMRTbell subreads.  
Error analysis 
 
The SMRTbell approach provides multiple reads of both the forward and reverse 
strands of each individual DNA molecule, and these sequences are then combined into a 
consensus sequence.  This redundancy greatly reduces, but does not eliminate, sequence 
errors inherent to the PacBio sequencing process.  To provide an initial assessment of the 
presence of sequence errors, preliminary alignments of sequences from the 2337C sample 
with the reference parental sequence (GenBank U76405) was performed.  Because prior 
Sanger sequencing of a 2337C vlsE PCR product matched U76405, it was expected that 
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most, if not all, of the PacBio sequences would have the same sequence.  However, it was 
found that many of the reads had one or more sequence differences.  Therefore a more 
thorough analysis of the occurrence of sequence errors was done.      
In this analysis, 127 reads from the 2337C sample were manually aligned with 
U76405 and the 15 silent cassettes using the program BioEdit to determine the frequency 
and locations of sequence differences.  The total number of sequences with errors at each 
position in aligned read was graphed. Error analysis of 127 reads from sample 2337C 
showed that the positions with the highest frequency of errors were deletions of guanine 
within polymeric G-runs (Figure 3.2). The positions that had errors in 20 sequences or 
more are labeled above the corresponding bar. The locations of these common sequence 
errors were consistent in the error analysis of manually aligned reads for the other 
samples. In order to have a systematic approach when manually aligning sequences, the 
guanine deletion errors within homopolymer runs were always assigned to the last G in the 
stretch instead of being equally distributed among all the Gs. Therefore, the number of 
errors at these terminal G positions are overstated while the number of errors of the non-
terminal Gs in homopolymer runs are underreported. These results show that PacBio 
sequencing errors in homopolymers are not random and instead occur at a higher rate 
compared to errors at other positions. Fortunately, errors in homopolymer G runs are 
easily fixed and hence the majority of the sequencing errors can be fixed unambiguously.  
The error rate was calculated by dividing the total number of errors found in a 
sequence by the read length of the aligned sequence (609 bp). To find the error rate of a 
sample, the number of sequence differences of individual reads was averaged.  In general, 
errors could be distinguished easily from recombination events; nearly all were non-
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templated single base insertions or deletions, which were not observed previously in the 
analysis of 1,496 clones by Sanger sequencing [29]. The error rate for manually aligned 
reads ranged from 0.74% to3.2% (Table 4). The error rate could be related to the freshness 
of the samples. The DNA from mouse infection samples was derived from spirochetes 
grown out from tissue in BSKII medium, while the remaining samples were from stored 
frozen cultures or DNA. This could explain why D7M1B reads had the lowest error rate 
(Table 4).  
Because most of the sequences contained errors, it was important to do an error 
analysis that showed the sequence changes are a result of recombination events. First, the 
mismatch, deletion and insertion error rate was calculated at several non-variant codon 
positions (same codon sequence across vlsE and 15 silent cassettes).  For example, the 
codon at position 49 (Figure 3.4B) is a non-variant codon that has ‘AGT’ across all 16 
cassettes. The mismatch error rate represents the inherent error rate per base present in 
the sequences. Sample 2337C had 0.023% mismatch error rate, 0.40% deletion error rate, 
and 0.20% single insertion error rate. Given the mismatch error rate of 0.023%, the odds of 
a vlsE sequence without any mismatch errors is 0.977. I then compared the mismatch error 
rate against the rate of change of bases at variant codon positions from a vlsE sequence to 
one of the 15 vls sequences. For instance, for sample 2337C variants, the rate of change at 
codon 38 was 11%. 11% is much higher than the calculated mismatch error rate of 0.023%, 
therefore the sequences with changes at codon 38 are real changes and not result of errors. 
Overall, this error analysis proves that the probability of having random base changes is 
extremely low and therefore most of the changes in the variant sequences result from 
recombination event(s).  
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FASTQ analysis 
In order to evaluate the quality of PacBio consensus sequences, FASTQ files of each 
sample were analyzed. FASTQ files contain the quality scores associated with each base call 
for every read. The quality scores were represented as ASCII characters and the ASCII table 
was used to convert the ASCII characters into a phred or Q score. Essentially, the quality 
scores represent the probability of a base being called incorrectly. This probability is 
calculated using the formula P = 10–Q/10, where P is the error probability and Q is the 
quality score.  
The majority of the base calls had the ASCII character of K (corresponding to the 
11th highest quality score and P_error= 0.07943). This was true for FASTQ files for all the 
samples. In order to evaluate the quality of individual reads, a quality ratio was generated 
for every sequence. The quality ratio was calculated by dividing the total number of bases 
with the ASCII score of K or higher by the total read length. Figure 3.3 shows that there is a 
negative correlation between the quality ratio and the total number of errors in a read. As 
the total number of errors in a sequence increases, the quality ratio decreases. The 
correlation between these two variables indicates that the quality ratio could be used to 
accurately assess the quality of a read and ultimately help filter out low quality sequences. 
Detection of real recombination events 
Sequences that appeared to contain recombination events were identified by local 
BLAST searches of each read against segments of the vlsE1 cassette region and the 15 vls 
silent cassettes (see Materials and Methods).  Those sequences that contained regions that 
had higher sequence identity with a silent cassette segment than with the parental vlsE 
sequence were considered to have potential recombination events.  These were further 
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verified through manual alignments.  Because of their relatively small number, all of the 
potential variants could be analyzed in the 2337C, 5A18NP1, and the infected tissue 
explant TE47, TE49, TE50 samples.  For day 7 mouse bladder samples, which contained a 
high number of variants, the first 200 sequences were analyzed by manual alignment. The 
percentage of variants was 0.84% to 1.18% in pure in vitro cultures derived from parent 
strain B31, and 0.79% to 1.22% in the tissue explant co-culture (Table 4). In contrast, 36% 
to 57% of the first 200 sequences from day 7 mouse bladder samples were variants. Within 
the population of variants the number of variants with siblings (identical variant sequences 
within the same sample) were counted. 11 to 63 variants with siblings were found in the 4 
samples analyzed (Table 4).  Thus most (67 to 91 percent) of the variant sequences 
identified in this analysis were unique. 
After manually aligning potential variant reads, the reads were entered into a Visual 
Basic macros program. This program visually displays all potential silent cassette donors 
that match the non-parental sequence of variant sequences. The length of recombination 
events ranged from a single nucleotide change to almost the entire cassette. Figure 3.4 
shows the Visual Basic macros program output for one variant read from sample 2337C.  
Figure 3.4A shows the overall pattern of recombination in read 2337C_139710, whereas 
Figure 3.4B provides a close-up of the variant region. The different colored bars represent 
silent cassettes 2-15.  The solid color represents where the variant sequence matches to a 
silent cassette, while the surrounding lighter hatched colored region represents where the 
variant sequence matches both the silent cassette and vlsE1. Therefore, the maximal 
recombination event is inclusive of the surrounding lighter colored regions, while the 
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minimal recombination event starts at the first change that is unique to a silent cassette 
(solid color) and ends at the last change that is unique to the same silent cassette.   
In many cases, a single vls cassette could be deduced as the donor to a 
recombination event. For example, read 2337C_139710 has non-‘parental’ sequence within 
its VR1 region (Figure 3.4A). The putative cassette donor for this variant sequence is vls3 
because it encompasses all the non-‘parental’ sequence of the aligned variant read in one 
consecutive segment. The minimal recombination event extends from codon 39 to 42, 
while the maximal recombination event extends from codon 9 to 68.  Figure 3.5 shows the 
schematic representation of three additional variants from sample 2337C. Read 
2337C_42395 has a single well-defined recombination event with a minimal recombination 
event length of a single nucleotide (Figure 3.5A). The putative cassette donor is vls2. Read 
2337C_103644 also has a single well-defined recombination event; vls3 is the putative 
silent cassette donor and it has a 486-nucleotide long minimal recombination event. In 
contrast, read 2337C_101310 has several intermittent sequence differences that can be 
considered multiple recombination events (Figure 3.5B).  Furthermore, most of the 
changes in 2337C_101310 cannot be attributed to a single silent cassette, due to the 
redundancy that occurs within regions of the silent cassettes.  
Analysis of manually aligned variant reads 
Variants reads were translated to their protein sequence and then compared against 
the ‘parental’ vlsE sequence. The sequences with a non-parental amino acid at each position 
were totaled. Results showed that, as expected, the majority of the non-parental amino 
acids, or recombination events in variant sequences were within the variable regions 
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(Figure 3.6). This is consistent with prior studies that also showed that most sequence 
changes are concentrated in the variable regions [29]. 
To study the length of individual recombination events, variant sequences with a 
single well-defined recombination event were further examined. The length of the single 
recombination event and the putative silent cassette donor was recorded for all variant 
sequences.  The average length of a minimal recombination event of variants from sample 
2337C was 48 codons, 33 codons for sample 5A18NP1, 3 codons for sample TE47, and 7 
codons for sample D7M1B. The longest length of a minimal recombination event was 172 
codons (the entire length of vlsE is 203 codons) for variants with single well defined 
recombination events from both mammalian-cell free in vitro samples: 2337C and 
5A18NP1.  In contrast, the longest minimal recombination event was 35 codons long for 
both TE47 and D7M1B (Figure 3.7A). The results indicate that variants from mammalian 
cell-free (axenic) samples had a higher frequency of longer minimal recombination events 
than the variants from tissue explant co-cultures and infected mice samples (Figure 3.7A). 
 Figure 3.7B shows the usage of silent cassettes in variant sequences with single 
recombination events. While most sequences changes in aligned variant reads with a single 
recombination event could be attributed to one of the 15 silent cassettes, some of the 
sequences had template-independent changes, or apparent point mutations. It is unclear 
whether these all these sequence differences represent a real genetic change or a 
sequencing error. 
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Table 3. Total number of reads obtained and number of reads that had a read length of > 
601 bp and < 680 bp. 
 
Sample name 
 
Total number of reads 
 
Number of reads > 601 bp 
and < 680 bp 
 
Parental clone (2337C) 35,699 15,184 
Parental clone (5A18NP1) 29,259 12,136 
Tissue explant (TE47) 29,536 12,762 
Tissue explant (TE49) 23,913 11,076 
Tissue explant (TE50) 31,861 14,025 
D7M1B 24,042 10,036 
D7M2B 20,601 8,393 
D7M3B 28,981 10,875 
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(A) 
 
(B)  
>vlsE1 
GAGGGGGCTATTAAGGAAGTTAGCGAGTTGTTGGATAAGCTGGTAAAAGCTGTAAAGACAGCTG
AGGGGGCTTCAAGTGGTACTGCTGCAATTGGAGAAGTTGTGGCTGATGCTGATGCTGCAAAGGT
TGCTGATAAGGCGAGTGTGAAGGGGATTGCTAAGGGGATAAAGGAGATTGTTGAAGCTGCTGGG
GGGAGTGAAAAGCTGAAAGCTGTTGCTGCTGCTAAAGGGGAGAATAATAAAGGGGCAGGGAAGT
TGTTTGGGAAGGCTGGTGCTGCTGCTCATGGGGACAGTGAGGCTGCTAGCAAGGCGGCTGGTGCT
GTTAGTGCTGTTAGTGGGGAGCAGATATTAAGTGCGATTGTTACGGCTGCTGATGCGGCTGAGC
AGGATGGAAAGAAGCCTGAGGAGGCTAAAAATCCGATTGCTGCTGCTATTGGGGATAAAGATGG
GGGTGCGGAGTTTGGTCAGGATGAGATGAAGAAGGATGATCAGATTGCTGCTGCTATTGCTTTG
AGGGGGATGGCTAAGGATGGAAAGTTTGCTGTGAAGGATGGTGAGAAAGAGAAGGCT 
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Figure 3.2 Nucleotide positions with the highest number of errors were deletions of 
guanines in homopolymer G-runs.   
(A) This error analysis graph represents the 127 variants sequences from sample 2337C. 
The total number of errors was calculated at each position in the aligned sequence. The 
positions with highest number of errors were homopolymer G-runs. The bars that have 
position numbers above the peak represent these positions. For polymeric G-runs, the 
deletion error was always assigned to the last G base in the run, and not rationed equally 
across all of the Gs. Therefore, the error rate for the last G is overstated and under-reported 
for the other Gs in the G-run. 
(B) The homopolymer G-runs within vlsE1 sequence are underlined and positions with 
highest number of errors are in red. vlsE is highly GC rich and has a total of 12 guanine 
homopolymer runs. PacBio sequencing appears to have a sequencing error bias in 
homopolymer runs. 
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Figure 3.3 There is an inverse correlation between the quality score and total 
number of errors. 
This graph analyzes variant sequences from sample 2337C. The quality ratio was calculated 
by dividing the total number of base calls with ASCII quality score of K or greater by the 
total read length. The quality ratios for sequences with the same number of errors were 
averaged. There is a negative correlation between the number of errors and the average 
quality ratio. Sequences with higher numbers of errors tend to have a lower quality ratio, 
while sequences with low numbers of errors tend to have a higher quality ratio. This 
correlation suggests that FASTQ will be useful for identification and filtering of low quality 
reads.  
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Table 4.  Percent variants detected in samples and the calculated error rate. The error rate 
of each sample was calculated by averaging the error rate of individual variant reads. The 
error rate of a single sequence is the total number of errors divided by the read length. 
Sibling sequences are sequences that have the same vlsE variant sequence. 
*Number of reads from TE49 and TE50 samples were additionally filtered for high quality 
scores.  
 
Sample name Number of 
reads > 601 
and < 680 
Number of 
variants 
Percent of 
variants 
Error rate Number of 
sequences 
with siblings 
2337C 15,184 127 0.84% 1.58% 14 
5A18NP1 12,136 143 1.18% 2.5% 14 
TE47 12,762 102 0.80% 3.2% 11 
TE49 11,076 127 1.02% 0.89% 63 
TE50 14,025 126 1.22% 0.74% 57 
D7M1B-1st 
200 reads 
200 (1st 200 
reads > 601 
and < 680) 
 
114 57% 0.96% 17 
D7M2B-1st 
200 reads 
200 (1st 200 
reads > 601 
and < 680) 
 
72 36% 0.92% 21 
D7M3B-1st 
200 reads 
200 (1st 200 
reads > 601 
and < 680) 
105 52.5% 1.01% 14 
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Table 5. Chi-square test using in vitro and tissue explant samples 
*The Day 7 Mouse samples are excluded from this analysis. 
 
Item Group-1 (in vitro culture) Group-2 (tissue explant) Total 
Observed 
numbers (O) 
0.99% 0.94% 1.93E-02 
Expected 
numbers (E) 
1.0% 1.01% 2.02E-02 
O - E -0.02% -0.08% -9.46E-04 
(O-E)2 3.64E-08 5.70E-07 6.06E-07 
(O-E)2 / E 3.61E-06 5.63E-05 5.99E-05 
 
Critical Chi-square statistic for DF = # of groups -1= 2-1 =1 and 5% significance level 
 
Conclusion:  
As the calculated chi-square statistic (5.99E-05) is less than the Critical Chi-square statistic (3.84), 
the Null Hypothesis can't be rejected. 
Thus, it can be concluded that the number of variants found tissue explant samples (Group-2) is not 
statistically different the number of variants found in in vitro culture samples (Group-1). 
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    (B)      
 
       
 
 
 
 
 
37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 
GCT GAT GCT GAT GCT GCA AAG GTT GCT GAT AAG GCG AGT GTG AAG 
OOO OOO OOO OOO OOO OOO OOO OOO OOO OOO OOO OOO OOO OOO OOO 
GCT GAT GAT AAT GCT GCG AAG GTT GCT GAT AAG GCG AGT GTG AAG 
GCT AAT GCT GGT GCT GCA AAG GTT GCT GAT AAG GCG AGT GTG ACG 
GAT AAT OOO OOO GCT GCG AAG GCT GCT GAT AAG GCG AGT GTG ACG 
GAT AAT OOO OOO GCT GCG AAG GCT GCT GAT AAG GAT AGT GTG ACG 
GCT GAT GCT OOO GCT OOO AAG GTT GCT GAT AAG GCG AGT GTG ACG 
GAT AAT GCT GGT GCT GCG AAG GCT GCT GAT AAG GAT AGT GTG AAG 
GAT AAT OOO GAT GCT OOO AAG GTT GCT GAT AAG GCG AGT GTG ACG 
GAT AAT OOO GAT OOO GCG AAG GCT GCT GAT AAG GCG AGT GTG ACG 
GCT AAT GCT GGT GCT GCG AAG GCT GCT GAT AAG GCG AGT GTG ACG 
GCT GAT OOO OOO GCT GCG AAG GCT GCT GAT AAG GAT AGT GTG AAG 
GCT GAT GAT GCT GCT GCG AAG GCT GCT GAT AAG GAG AGT GTG AAG 
GCT AAT GAT GCT GCT GCG AAG GTT GCT GAT AAG GAG AGT GTG ACG 
GAT AAT AAT AAT GCT GCG AAG GCT GCT GAT AAG GCG AGT GTG ACG 
GCT GAT AAT AGT GCT GCG AAG GCT GCT GAT GAG GCG AGT GTG ACG 
GCT GAT GAT AAT GCT GCG AAG GTT GCT GAT AAG GCG AGT GTG AAG 
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Figure 3.4 Visual representation of a vlsE variant and all potential silent cassette donor 
(A) The variant read 2337C_139710 has a single recombination event within VR1 with 
the minimal recombination event length of 4 codons. The putative cassette donor is vls3 
because it contains the longest contiguous matching segment. 
(B) The bottom panel shows the magnified VR1 region of 2337C_139710 recombination 
pattern and where it matches vls3. The top table shows the vlsE, 15 silent cassettes and the 
2337C_139710 sequence. The brown solid colored regions represent where the change in 
2337C_139710 is present in vls3. The lighter colored hatched region adjacent to solid 
colored region are identical to vlsE1, the vls3 silent cassette and the variant sequence. The 
yellow boxed regions indicate where 2337C_139710 matches vls3 sequence. The 
recombination event most likely used vls3 as a template, because it is the only silent 
cassette that matches all three codon changes.
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(A) 2337C_127488 
 
 
(B) 2337C_103644 
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(C) 2337C_101310 
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Figure 3.5 Visual representation of three vlsE variants and all potential silent 
cassette donors. 
 
(A) The variant read 2337C_127488 has a single recombination event within VR1 with the 
minimal recombination event length of a single nucleotide. The putative cassette donor is 
vls3 (orange) because it is the only cassette that matches that sequence change.  
(B) Read 2337C_103644 has a single, long, well-defined recombination event that has a 
minimal recombination event that extends from VR1 to VR6, and has a length of 486 
nucleotides. The putative donor is vls3 (brown) because it is the only silent cassette that 
matches the entire range of the recombination event.  
(C) Variant read 2337C_101310 has multiple recombination events. The deduced number 
of recombination events is 4 because there are 4 intermittent segments that match silent 
cassettes. A single putative cassette donor cannot be determined for 3 of the 4 sequence 
changes. vls2 is the most likely donor for the right-hand recombination event spanning 
from VR3 to VR4. 
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Figure 3.6 Majority of non-‘parental’ amino acid sequences in variant sequences 
were within the expected lengths of the variable regions.  
The variant nucleotide sequences were translated into amino acid sequences and then 
compared against the parental vlsE amino acid sequence. The majority of the positions with 
non-parental amino acid sequence were within the variable regions.  
0
0.05
0.1
0.15
0.2
0.25
0.3
IR1 VR1 IR2 VR2 IR3 VR3 IR4 VR4 IR5 VR5 IR6 VR6
P
ro
p
o
rt
io
n
 D
if
fe
re
n
t 
fr
o
m
 v
ls
E
1
Invariable and variable regions
 57 
 
(A) 
 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
1 11 21 31 41 51 61 71 81 91 101 111 121 131 141 151 161 171
F
re
q
u
e
n
cy
 p
ro
p
o
rt
io
n
Length of minimal recombination event
2337C-frequency
TE47-frequency
D7M1B-frequency
5A18NP1-frequency
2337C-cumulative freq
TE47-cumulative freq
D7M1B-cumulative freq
5A18NP1-cumulative freq
 58 
(B) 
 
 
 
 
Figure 3.7 Lengths of minimum recombination events in variant sequences with a 
single, well-defined recombination event. 
(A) For each sample, the length of the minimal recombination event in variant sequences 
with a well defined single recombination event was graphed against the frequency 
proportion. The cumulative frequency of sequences that have a minimal recombination 
event length that is less than or equal to a set length is shown by the line graph.  
(B) Along with the length of the minimal recombination event, the deduced cassette donor 
for variant sequences with a single recombination event were counted and graphed. Some 
sequences with a single recombination event had a single nucleotide change as point 
mutations (pm).  
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 Both qPCR and high throughput sequencing were effective methods in 
detecting and quantifying vlsE variants. This is the first time vlsE recombination has 
been shown to occur in in vitro mammalian cell-free cultures and tissue explant co-
cultures. In both methods, the difference in the number of variants found in axenic in 
vitro samples and tissue co-culture samples was not statistically significant. The 
results from the previous chapter suggest that not only is there a difference in the 
rate of recombination among axenic culture, tissue explant co-culture and infected 
mice samples, but there is also a difference in the nature and extent of antigenic 
variation. 
qPCR results  
  We were able to standardize a qPCR protocol that allowed us to use absolute 
quantification to compare the rate of vlsE recombination in axenic, tissue explant co-
culture and animal infection samples. Two primer pairs were used, one for detecting 
parental vlsE and the other for detecting variant vlsE. Both primer pairs are specific 
for detecting whether the VR5 region has undergone a change.  The variant primer 
detects variants with a change in VR5 region; therefore the parental primer and not 
the variant primer will amplify any variants with an unchanged VR5 region.  Given 
that 12 of 15 silent cassettes have a VR5 sequence that differs from the parental 
sequence at the priming site, a positive PCR result would be expected in ~80% of 
clones with a recombination event in the region.  In addition, recombination events 
occurring in other portions of the vlsE cassette region would not be detected by this 
method.  Therefore this qPCR method provides an indication of the extent of 
recombination in a B. burgdorferi population, but does not provide an estimate of, for 
 61 
example, the proportion of clones that have a recombination event in any location 
within the vlsE cassette. 
 The optimized qPCR assay had linear standard curves with R2 values > 0.979, 
high amplification efficiency (> 99%), and consistency across replicates. Using 
absolute quantification standard curves, we found that the percentage of variants 
was 2.97% in sample 2337C, 99.98% in 1396D, 7.97% in TE47, 12.42% in D7M1B, 
39.42% in D14M1B, 78.57% in D28M1B (Table 3.2). Comparing the percent of 
variants found in samples 2337C and TE47, the difference was not statistically 
significant. Similar to the results observed in prior studies, the qPCR assay showed 
an increase in the accumulation of variants between day 7 and day 28 post-infection 
in mice. However, the percentage of variants calculated by qPCR absolute 
quantification in sample 2337C and TE47 was higher than the percentage of variants 
found by high-throughput sequencing. This is most likely the result of the inherent 
differences between the two methodologies.  
PacBio sequencing results 
High-throughput sequencing of vlsE PCR products generated a large amount 
of data with approximately 30,000 reads per sample. Despite the presence of 
sequencing errors, we were able to manually align sequences against 16 pre-aligned 
cassettes. The error analysis showed that we were able distinguish real vlsE variants 
from sequence errors.  The majority of sequencing errors are within invariant 
regions of vlsE and therefore could be unambiguously ’repaired’. Most of these errors 
are deletions of guanine within a homopolymer G-run. This demonstrates that like 
many other sequencing platforms PacBio may also have difficulties sequencing GC-
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rich, repetitive sequences or stretches of homopolymer DNA. Several other studies 
have also reported that deletion errors are twice as common as substitution and 
insertion errors in PacBio sequencing [40].  
TG insertions (which would result in frameshifts) are found in single locations 
of two vls silent cassettes, vls14 and vls16. Otherwise, all other relative indels in the B. 
burgdorferi B31 vls cassette regions occur in multiples of three nucleotides, thus 
preserving the open reading frame [26].  This same pattern has been found in all 
Lyme disease Borrelia vls loci examined [27].  Furthermore, a single-base indel was 
found in only one of 1,399 vlsE sequences examined by Coutte et al. [29] by Sanger 
sequencing. These findings provide further confidence that the single nucleotide 
indels found in the PacBio sequences represent sequence errors.   
In this study, manual alignments and sequence corrections were performed 
on 486 PacBio sequences to permit evaluation of the frequency and nature of vlsE 
recombinations that occurred under the conditions examined. This analysis provided 
a view of the previously undetected vlsE variation in axenic cultures, as well as in 
tissue explants and in infected mice. 
Analyses of axenic cultures samples (2337C and 5A18NP1) revealed that 
approximately 1% of the sequences were variant vlsE. According to our hypothesis, 
we expected to see a significantly higher number of variants within the tissue explant 
co-culture samples than the number of variants detected in axenic culture. Looking at 
the number of variants found in samples, there was not a significant difference 
between the number of variants found in tissue explant co-culture samples (TE47, 
TE49, TE50) and the in vitro mammalian cell free samples (2337C, 5A18NP1). Thus 
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the data analyzed to date indicate that the recombination rate in vitro is not 
enhanced by the presence of mammalian tissue.  It is possible that not all variant 
sequences were found using the method of local BLAST to compare the raw reads 
against IR-VR regions.  Also, alteration of the tissue explant system may result in 
higher recombination rates.  Therefore, additional analysis is needed to reinforce this 
initial finding.  
To find the number of variants in mouse infection samples (mouse bladder 
tissue 7 days post inoculation), 200 sequences were manually aligned. Fifty-seven 
percent of those 200 sequences were found to have alterations. These results are in 
agreement with prior studies, which showed ~50% of clones recovered from mice at 
7 days post infection had a variant vlsE sequence [27]. The similarity in the number 
of variants found in day 7 mouse infection samples in this study and former studies 
further help to support PacBio sequencing as a valid method for quantitating the rate 
of vlsE recombination.  
Across all variant sequences, the majority of the changes occurred within the 
proposed variable regions. This result supports prior studies presented in Coutte et 
al. [27]. The conserved regions of VlsE may preserve the protein structure or 
functionality, serving as a ‘scaffold’ for the variable regions.  
Analysis of variants with single well-defined recombination events showed 
that the mammalian cell-free in vitro samples had more variants with longer minimal 
recombination than the tissue explant co-culture and infected mouse samples. This 
distinction could be indicative of a mechanistic difference in vlsE recombination 
when in in vitro (axenic samples) and when in the presence of mammalian cells 
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(tissue explant co-cultures and mouse infected tissue samples). A different set of 
proteins may be involved when vlsE recombination occurs in an in vitro mammalian 
cell free environment that results in longer minimal recombination events. 
Interestingly, like the variant reads from axenic in vitro sample, the variant vlsE 
sequences recovered from ruvAB mutants also had long minimal recombination 
events. This observation further supports the proposition that additional proteins 
involved in recombination may be expressed and active in the mammalian host than 
in an axenic environment.  
Some of the single recombination events were template-independent point 
mutations. It is not clear whether these are real point mutations caused by genetic 
change or sequencing errors. The average quality ratio for variants with a point 
mutation as the single well defined recombination event was lower than the average 
quality ratio for the remaining variants with a single recombination event (data not 
shown). Therefore, it is likely that some the point mutations are sequencing errors.  
VlsE has not been shown to have a function other than helping B. burgdorferi 
evade host immune response by varying its sequence. It is also possible that the 
proteins required for an increase vlsE recombination rate are activated at specific 
environmental conditions such as pH, temperature, and osmolarity. Previous studies 
have shown that vlsE recombination can occur within SCID mice, and therefore the 
adaptive immune response does not play a role in the induction of vlsE 
recombination [33]. It is also unlikely that host proteins are internalized by B. 
burgdorferi and are used in vlsE recombination because that would require the host 
proteins to penetrate the bacterial membrane. Interaction between specific host 
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proteins and the surface exposed VlsE may be required to activate the proteins that 
play a role in increasing the rate of vlsE recombination in the mammalian host.   
Conclusion and future perspectives  
  In this study, we developed a protocol using PacBio sequencing to identify 
real vlsE variants in samples from mammalian cell-free in vitro cultures, tissue 
explant co-cultures and mouse infection studies. High-throughput sequencing 
generated large amounts of data that allowed us to detect rare recombination events.  
vlsE recombination has been shown to occur in random segmental changes that can 
include a single base change to almost the entire cassette. Therefore, the study of vlsE 
variants is sensitive to sequencing errors. Despite the PacBio sequencing results 
being hampered by errors, we were able to unambiguously fix a majority of the 
errors.  
There seems to be an intrinsic low level of vlsE recombination occurring in 
axenic cultures, which is enhanced when in mammalian host. We found that the 
length of a recombination event in variant sequences with a single well defined 
recombination event were longer in mammalian cell-free samples than in tissue 
explant and mouse infection samples. This may be the result of a different set of 
proteins being activated during vlsE recombination in in vitro and in in vivo. We also 
developed a qPCR assay that is a sensitive and relatively simple means of assessing 
the frequency of vlsE recombination in a sample. The qPCR results corroborate the 
PacBio sequencing results, as both methods detected the occurrence of vlsE variation 
in axenic cultures and showed increases during mouse infection.  Also, both 
approaches indicated that there was not a significant difference between the number 
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of variants found in the mammalian cell-free and the tissue explant co-culture 
samples.   
It might be possible to increase the sensitivity of the qPCR assay by 
standardizing tissue weight prior to DNA extraction. For the next sequencing 
experiments, we will be looking into whether there is a difference in the error rate 
between the SMRTbell sequencing of the sense and antisense strand of a single 
molecule. If there is a significant difference, averaging the strand with the lower 
error rate will result in a higher quality consensus read.  
 The remaining samples from mouse infection studies will be sequenced and 
analyzed. This includes joint, bladder, heart, skin, and ear tissue samples from days 7, 
14, 28, 60, and 90 post infection. To further understand the effect of passage number 
on the number of variants detected in mammalian cell-free in vitro culture, we will be 
sending clone samples that have undergone 1-10 passages. We also plan to sequence 
another B. burgdorferi gene with the same GC content as vlsE. This approach will 
allow us to better measure the error rate in PacBio sequencing.  We will be using the 
automation program to align sequences and make error corrections.   
 Furthermore, the protocol developed in this study using PacBio high-
throughput sequencing and qPCR to study vlsE recombination could be applied to 
study other antigenic variation systems. For example, Neisseria gonorrhoeae, the 
causative agent of the sexually transmitted disease gonorrhea, varies its pilE 
sequence. Other examples are the previously described T. brucei system,  the Vlp 
family of lipoproteins in Mycoplasma hyrohini, and Msp2 antigenic variation in 
Anaplasma phagocytophilum [41]. 
 67 
Chapter 5 
Bibliography 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 68 
1. Tilly, K., P.A. Rosa, and P.E. Stewart, Biology of infection with Borrelia 
burgdorferi. Infectious Disease Clinics of North America, 2008. 22(2): p. 217-
234. 
2. Adeolu, M. and R.S. Gupta, A phylogenomic and molecular marker based 
proposal for the division of the genus Borrelia into two genera: the emended 
genus Borrelia containing only the members of the relapsing fever Borrelia, and 
the genus Borreliella gen. nov. containing the members of the Lyme disease 
Borrelia (Borrelia burgdorferi sensu lato complex). Antonie Van Leeuwenhoek, 
2014. 105(6): p. 1049-72. 
3. Pritt, B.S., et al., Identification of a novel pathogenic Borrelia species causing 
Lyme borreliosis with unusually high spirochaetaemia: a descriptive study. 
Lancet Infect Dis, 2016. DOI S1473-3099(15)00464-8 [pii] 
10.1016/S1473-3099(15)00464-8. 
4. Mead, P.S., Epidemiology of Lyme Disease. Infect Dis Clin North Am, 2015. 
29(2): p. 187-210. 
5. Steere, A.C., et al., Lyme arthritis: an epidemic of olioarticular arthritis in 
children and adults in three Connecticut communities. Arthritis Rheum., 1977. 
20: p. 7-17. 
6. Schwan, T.G., W.J. Simpson, and P.A. Rosa, Laboratory confirmation of Lyme 
disease. Can. J. Infect. Dis., 1991. 2(2): p. 64-9. 
7. Sanchez, J.L., Clinical Manifestations and Treatment of Lyme Disease. Clinics in 
Laboratory Medicine, 2015. 35(4): p. 765-778. 
8. Bogdos, M., S. Giannopoulos, and M. Kosmidou, The conflict on posttreatment 
Lyme disease syndrome: a clinical mini review. Neuroimmunology and 
Neuroinflammation, 2016. 10(3). 
9. Bacon, R.M., et al., Serodiagnosis of Lyme disease by kinetic enzyme-linked 
immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia 
burgdorferi compared with 2-tiered testing using whole-cell lysates. J. Infect. 
Dis., 2003. 187(8): p. 1187-99. 
10. Arvikar SL, S.A., Diagnosis and treatment of Lyme arthritis. Infectious Disease 
Clinics of North America, 2015. 29(2): p. 269-280. 
11. Fraser, C.M., et al., Genomic sequence of a Lyme disease spirochaete, Borrelia 
burgdorferi. Nature, 1997. 390(6660): p. 580-586. 
12. Purser, J.E. and S.J. Norris, Correlation between plasmid content and infectivity 
in Borrelia burgdorferi. Proc. Natl. Acad. Sci. USA, 2000. 97(25): p. 13865-
13870. 
13. Labandeira-Rey, M., E. Baker, and J. Skare, Decreased infectivity in Borrelia 
burgdorferi strain B31 is associated with loss of linear plasmid 25 or 28-1. 
Infect. Immun., 2001. 69: p. 446-455. 
14. Norris, S.J., Encyclopedia of Microbiology. 3 ed, ed. M. Schaechter. Vol. 1. 2009, 
San Diego: Elsevier. 
15. Steere, A.C., Lyme disease. N. Engl. J. Med., 1989. 321: p. 586-596. 
16. Yang, X., et al., Interdependence of environmental factors influencing reciprocal 
patterns of gene expression in virulent Borrelia burgdorferi. Mol. Microbiol., 
2000. 37(6): p. 1470-9. 
 69 
17. Schwan, T.G. and J. Piesman, Temporal changes in outer surface proteins A and 
C of the Lyme disease- associated spirochete, Borrelia burgdorferi, during the 
chain of infection in ticks and mice. J. Clin. Microbiol., 2000. 38(1): p. 382-8. 
18. Samuels, D.S. and J.D. Radolf, Borrelia: Molecular Biology, Host Interaction and 
Pathogenesis. 2010, Hethersett, Norwich, UK: Caister Academic Press. 
19. Norris, S.J., et al., Pathobiology of Lyme disease Borrelia, in Borrelia: Molecular 
and Cellular Biology, D.S. Samuels and J.D. Radolf, Editors. 2010, Caister 
Academic Press: Hethersett, Norwich, UK. p. 299-331. 
20. van der Woude, M.W. and A.J. Bäumler, Phase and antigenic variation in 
bacteria. Clin. Microbiol. Rev., 2004. 17(3): p. 581-611. 
21. Cornelis Vink, G.R., H. Steven Seifert, Mircrobial antigenic variation mediated 
by homologous DNA recombination. FEMS Microbiol 2012: p. 917-948. 
22. Cahoon, L.A. and H.S. Seifert, An alternative DNA structure is necessary for pilin 
antigenic variation in Neisseria gonorrhoeae. Science, 2009. 325(5941): p. 
764-767. 
23. Cahoon, L.A., Seifert HS., Transcription of a cis-acting, Noncoding, Small RNA Is 
Required for Pilin Antigenic Variation in Neisseria gonorrhoeae. PLoS Pathog, 
2013. 
24. Norris, S.J., Antigenic variation with a twist - the Borrelia story. Mol. Microbiol., 
2006. 60(6): p. 1319-22. 
25. Dai, Q., et al., Antigenic variation by Borrelia hermsii occurs through 
recombination between extragenic repetitive elements on linear plasmids. Mol. 
Microbiol., 2006. 60(6): p. 1329-43. 
26. Zhang, J.R., et al., Antigenic variation in Lyme disease borreliae by promiscuous 
recombination of VMP-like sequence cassettes. Cell, 1997. 89(2): p. 275-285. 
27. Norris, S.J., vls antigenic variation systems of Lyme disease Borrelia: Eluding 
host immunity through both random, segmental gene conversion and 
framework heterogeneity. Microbiol Spectr, 2014. 2(6): p. doi: 
10.1128/microbiolspec.MDNA3-0038-2014. 
28. Zhang, J.R. and S.J. Norris, Genetic variation of the Borrelia burgdorferi gene 
vlsE involves cassette-specific, segmental gene conversion. Infect. Immun., 1998. 
66(8): p. 3698-3704. 
29. Coutte, L., et al., Detailed analysis of sequence changes occurring during vlsE 
antigenic variation in the mouse model of Borrelia burgdorferi infection. PLoS 
Pathog., 2009. 5(2): p. e1000293. 
30. Kurosawa, K. and K. Ohta, Genetic Diversification by Somatic Gene Conversion. 
Genes, 2011(2): p. 48-58. 
31. Eicken, C., et al., Crystal structure of Lyme disease variable surface antigen VlsE 
of Borrelia burgdorferi. J. Biol. Chem., 2002. 277(24): p. 21691-21696. 
32. Dresser, A.R., P.O. Hardy, and G. Chaconas, Investigation of the genes involved 
in antigenic switching at the vlsE locus in Borrelia burgdorferi: an essential role 
for the RuvAB branch migrase. PLoS Pathog., 2009. 5(12): p. e1000680. 
33. Lin, T., et al., Central role of the Holliday junction helicase RuvAB in vlsE 
recombination and infectivity of Borrelia burgdorferi. PLoS Pathog., 2009. 
5(12): p. e1000679. 
 70 
34. Liveris, D., et al., Borrelia burgdorferi vlsE antigenic variation is not mediated 
by RecA. Infect. Immun., 2008. 76(9): p. 4009-4018. 
35. Walia, R. and G. Chaconas, Suggested role for G4 DNA in recombinational 
switching at the antigenic variation locus of the Lyme disease spirochete. PLoS 
One, 2013. 8(2): p. e57792. 
36. Zhang, J.R. and S.J. Norris, Kinetics and in vivo induction of genetic variation of 
vlsE in Borrelia burgdorferi. Infect. Immun., 1998. 66(8): p. 3689-3697. 
37. Barbour, A.G., Isolation and cultivation of Lyme disease spirochetes. Yale J. Biol. 
Med., 1984. 57(4): p. 521-525. 
38. Kawabata, H., S.J. Norris, and H. Watanabe, BBE02 disruption mutants of 
Borrelia burgdorferi B31 have a highly transformable, infectious phenotype. 
Infect. Immun., 2004. 72(12): p. 7147-7154. 
39. Rhoads, A. and K. Fai Au, PacBio Sequencing and its Applications. Genomics, 
Proteomics & Bioinformatics, 2015. 13(5): p. 278-289. 
40. Laehnemann D, B.A., McHardy AC., Denoising DNA deep sequencing data—
high-throughput sequencing errors and their correction. Briefings in 
Bioinformatics, 2015. 17: p. 159-179. 
41. Palmer, G.H., T. Bankhead, and H.S. Seifert, Antigenic Variation in Bacterial 
Pathogens. Microbiolspec, 2016. 4(1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 71 
VITA 
Surabhi Tyagi was born in India on September 2nd 1991 to Deepa and Aditya Tyagi. 
Raised in Austin Texas, she graduated from McNeil High School and attended 
University of Texas at Austin in the fall of 2009. She studied Biology with a 
concentration in Computational Biology and received her Bachelor of Science degree 
in May 2013. She moved to Houston in the summer of 2013 and enrolled in The 
University of Texas Health Science Center Graduate School of Biomedical Science at 
Houston.  
 
